Dynavax Technologies Corp. said Stanley Plotkin plans to step down as a board member, effective May 31 at the company's annual meeting.
Plotkin, who has been on the immunotherapy company's board since 2005, will continue as scientific adviser for Dynavax.
Berkeley, Calif.-based Dynavax develops therapies for cancers, asthma and hepatitis.
